By L.B. Bohle
To get in touch with L.B. Bohle, simply fill out the form below.
Subscribe to Supplier
L.B. Bohle awarded ISO 50001 certification
Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, has successfully completed its application processes and inspections and has duly been awarded ISO 50001 certification for energy management.
The audit process was completed in November 2022 and the certification is effective from early 2023.
Towards greener performance
The ISO 50001 recognition joins L.B. Bohle existing certifications for ISO 9001 quality standards, ISO 14001 for environmental management system, ATEX explosion proofing for BTS conical sieving machine, and its status as a “Known Consignor“ for air transport under German LBA certification.
The latest certification is a key achievement for L.B. Bohle, which regards systematic energy management as a central plank in its overall corporate emphasis on high environmental and climate protections.
Assessing energy efficiency
The ISO 50001 standard deals with energy management. It assesses the overall energy efficiency of companies, with energy-consuming systems and processes in the company measured for performance against a long term aim of achieving continuous improvement in energy consumption.
To this end, organizational and strategic measures are taken to achieve a long-term improvement in energy-related performance.
About L.B. Bohle
Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.
Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, process monitoring and continuous manufacturing.
The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency, but also strengthen competitive edge and sustainability.
To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.
The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally it has sales and service subsidiaries in the USA (Warminster, PA) in India (Ahmedabad) , in Singapore and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.